Agenus Inc.
USPTO PatentsView assignee record - 51 granted patents across 8 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Agenus ranks #6,500 of 49,997 tracked US assignees by granted-patent volume, with 51 patents across 8 technology areas.
- #6,500
- of 49,997 US assignees by volume
- Top 26%
- by Innovation Score (44.2/100)
- 29.4
- avg claims per patent
- +280%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R6500 · US Corporation #6,500 · 51 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 51 grants
- UPPER-Q #6,500/49,997
- PHOTO-FINISH Adama Makhteshim
- CPC-NARROW C07K · 8 areas
- INNOV-PAR 44.2/100
- CLAIMS-DENSE 29.4 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +280% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Adama Makhteshim Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Agenus’s 44.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Agenus
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Agenus · this assignee
Agenus · this assignee
44 score
- BeiGene · near
BeiGene · near
44 score
- Genethon · near
Genethon · near
44 score
- MTS Systems · near
MTS Systems · near
44 score
- Sequenom · near
Sequenom · near
44 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Agenus's Innovation Score is 44.2/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Agenus?
Each dot is one of Agenus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Agenus’s own 29.4 claims/patent is ABOVE the 18.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Agenus's grants concentrate
Agenus Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2020 (9 grants) versus a trough of 2 in 2017. By volume, Agenus sits between Adama Makhteshim Ltd. and Built Robotics Inc..
Agenus's three-year grant acceleration
From 2019–2021 to 2022–2024, Agenus Inc. moved from 24 to 20 grants (0.83x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Agenus's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Adama Makhteshim
Adama Makhteshim Ltd.
51 patents
- Alphatheta
Alphatheta Corporation
51 patents
- Amvac Chemical
Amvac Chemical Corporation
51 patents
- AST & Science
AST & Science, LLC
51 patents
- Analytics For Life
Analytics For Life Inc.
51 patents
- Bauer Maschinen
Bauer Maschinen GmbH
51 patents
- Barracuda Networks
Barracuda Networks, Inc.
51 patents
- Built Robotics
Built Robotics Inc.
51 patents
- Agenus ◀
Agenus Inc.
51 patents
What this shows Agenus holds 51 patents at rank #6,503, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Agenus
By rank, the assignees closest to #6,503 in granted patent volume.
- Adama Makhteshim Ltd. #6,499 · 51 patents
- Alphatheta Corporation #6,500 · 51 patents
- Amvac Chemical Corporation #6,501 · 51 patents
- AST & Science, LLC #6,502 · 51 patents
- Analytics For Life Inc. #6,504 · 51 patents
- Bauer Maschinen GmbH #6,505 · 51 patents
- Barracuda Networks, Inc. #6,506 · 51 patents
- Built Robotics Inc. #6,507 · 51 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Agenus's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Agenus, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Agenus ranks #171 of 3,615 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (44 here).
Similar claim depth
Nearest assignees by average claims per patent (29.4 here).
Agenus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 26% higher than 74% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 3.9% |
| 2018 | 2 | 3.9% |
| 2019 | 6 | 11.8% |
| 2020 | 9 | 17.6% |
| 2021 | 9 | 17.6% |
| 2022 | 9 | 17.6% |
| 2023 | 5 | 9.8% |
| 2024 | 6 | 11.8% |
| 2025partial year | 3 | 5.9% |
Which technologies does Agenus Inc. patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Agenus Inc.'s patent record in context - here's where to go next.
- Agenus Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #6,500 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Agenus Inc. against Adama Makhteshim Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.